文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肝硬化中肠道微生物群的研究综述与展望:一项文献计量分析(2001 - 2023年)

Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001-2023).

作者信息

Zhu Xiaofei, Zhou Ziyuan, Pan Xiaxia

机构信息

Department of Infectious Diseases, Hangzhou Ninth People's Hospital, Hangzhou, China.

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Front Microbiol. 2024 Mar 14;15:1342356. doi: 10.3389/fmicb.2024.1342356. eCollection 2024.


DOI:10.3389/fmicb.2024.1342356
PMID:38550860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10972893/
Abstract

INTRODUCTION: The gut-liver axis has emerged as a focal point in chronic liver disorders, prompting more research into the role of the gut microbiota in liver cirrhosis. In individuals with liver cirrhosis, changes in the structure and function of the gut microbiota are closely tied to clinical prognosis. However, there is a scarcity of bibliometric evaluations conducted in this particular field. METHODS: This study is aiming to conduct a complete analysis of the knowledge structure and centers pertaining to gut microbiota in liver cirrhosis using bibliometric methods. Publications on gut microbiota and liver cirrhosis from 2001 to 2023 are sourced from the Web of Science Core Collection. For the bibliometric analysis, we employ VOSviewer, CiteSpace, and the R package "bibliometrix". RESULTS: Our study encompasses a comprehensive collection of 3109 articles originating from 96 countries, with notable contributions from leading nations such as the United States and China. The quantity of publications concerning the gut microbiota of liver cirrhosis rises annually. The University of California San Diego, Virginia Commonwealth University, Zhejiang University are the primary research institutions. World Journal of Gastroenterology publishes the most papers in this field, while hepatology is the most frequently co-cited journal. These publications come from a total of 15,965 authors, and the most prolific authors are Bajaj Jasmohan S., Schnabl Bernd and Gillevet Patrick M., while the most co-cited authors are Bajaj Jasmohan S., Younossi Zobair M., and Reiner Wiest. In addition, "dysbiosis", "gut microbiota", "intestinal barrier", "fecal microbiota transplantation", and "complement-system" are the primary keywords of research trends in recent years. DISCUSSION: This study offering a comprehensive insight into the research dynamics surrounding gut microbiota in patients with liver cirrhosis. It delineates the current research frontiers and hotspots, serving as a valuable guide for scholars.

摘要

引言:肠-肝轴已成为慢性肝病的一个焦点,促使人们对肠道微生物群在肝硬化中的作用进行更多研究。在肝硬化患者中,肠道微生物群的结构和功能变化与临床预后密切相关。然而,在这一特定领域进行的文献计量评估却很少。 方法:本研究旨在运用文献计量方法,对肝硬化中肠道微生物群的知识结构和研究中心进行全面分析。2001年至2023年关于肠道微生物群和肝硬化的出版物来源于科学网核心合集。对于文献计量分析,我们使用VOSviewer、CiteSpace和R包“bibliometrix”。 结果:我们的研究全面收集了来自96个国家的3109篇文章,美国和中国等主要国家贡献显著。关于肝硬化肠道微生物群的出版物数量逐年上升。加利福尼亚大学圣地亚哥分校、弗吉尼亚联邦大学、浙江大学是主要研究机构。《世界胃肠病学杂志》在该领域发表的论文最多,而《肝脏病学》是被引用最多的期刊。这些出版物共有15965位作者,发文量最多的作者是巴贾杰·贾斯莫汉·S、施纳布尔·伯恩德和吉勒维特·帕特里克·M,而被引用最多的作者是巴贾杰·贾斯莫汉·S、尤诺西·佐拜尔·M和赖纳·维斯特。此外,“生态失调”“肠道微生物群”“肠屏障”“粪便微生物群移植”和“补体系统”是近年来研究趋势的主要关键词。 讨论:本研究全面深入地了解了肝硬化患者肠道微生物群的研究动态。它描绘了当前的研究前沿和热点,为学者提供了有价值的指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/a7cc1d3ba87c/fmicb-15-1342356-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/aab34bec1dc0/fmicb-15-1342356-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/efde42efe993/fmicb-15-1342356-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/8a25c4ffd947/fmicb-15-1342356-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/f4ece293c033/fmicb-15-1342356-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/374f2193eba2/fmicb-15-1342356-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/678beaf5b2b9/fmicb-15-1342356-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/1e2b23448355/fmicb-15-1342356-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/a7cc1d3ba87c/fmicb-15-1342356-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/aab34bec1dc0/fmicb-15-1342356-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/efde42efe993/fmicb-15-1342356-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/8a25c4ffd947/fmicb-15-1342356-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/f4ece293c033/fmicb-15-1342356-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/374f2193eba2/fmicb-15-1342356-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/678beaf5b2b9/fmicb-15-1342356-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/1e2b23448355/fmicb-15-1342356-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/10972893/a7cc1d3ba87c/fmicb-15-1342356-g008.jpg

相似文献

[1]
Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001-2023).

Front Microbiol. 2024-3-14

[2]
Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023).

World J Gastroenterol. 2023-10-7

[3]
Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis.

Front Endocrinol (Lausanne). 2023

[4]
Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis.

Front Pharmacol. 2024-7-11

[5]
Global research trends in the field of liver cirrhosis from 2011 to 2020: A visualised and bibliometric study.

World J Gastroenterol. 2022-9-7

[6]
Immunological factors in cirrhosis diseases from a bibliometric point of view.

World J Gastroenterol. 2023-6-28

[7]
Comprehensive bibliometric and visualized analysis of research on gut-liver axis published from 1998 to 2022.

Heliyon. 2024-3-8

[8]
A decade of insight: bibliometric analysis of gut microbiota's role in osteoporosis (2014-2024).

Front Med (Lausanne). 2024-5-22

[9]
Global research trends on the links between intestinal microbiota and liver diseases: a bibliometric analysis.

Am J Transl Res. 2023-8-15

[10]
Research trends and hotspots in exercise interventions for liver cirrhosis: A bibliometric analysis via CiteSpace.

Medicine (Baltimore). 2024-7-12

引用本文的文献

[1]
Unraveling the link between metabolic dysfunction-associated steatotic liver disease and osteoporosis: a bridging function of gut microbiota.

Front Endocrinol (Lausanne). 2025-4-1

[2]
Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota.

Front Med (Lausanne). 2025-3-7

[3]
Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension.

Front Med (Lausanne). 2025-1-31

[4]
Global trends in migraine and anxiety over the past 10 years: a bibliometric analysis.

Front Neurol. 2025-1-22

[5]
Gut microbiome composition in patients with liver cirrhosis with and without hepatic encephalopathy: A systematic review and meta-analysis.

World J Hepatol. 2025-1-27

[6]
Hotspots and research trends of gut microbiome in polycystic ovary syndrome: a bibliometric analysis (2012-2023).

Front Microbiol. 2025-1-8

[7]
Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study.

World J Hepatol. 2024-6-27

本文引用的文献

[1]
L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced Mice.

Nutrients. 2023-8-29

[2]
Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis.

Front Cell Infect Microbiol. 2023

[3]
Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database.

Biology (Basel). 2023-4-27

[4]
Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.

Front Microbiol. 2023-3-24

[5]
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response.

Hepatol Int. 2023-8

[6]
Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis.

Biomaterials. 2023-4

[7]
Acetyltransferase from blunts colorectal tumourigenesis by reprogramming tumour microenvironment.

Gut. 2023-7

[8]
Gut Lactobacillus and Probiotics Lactobacillus lactis/rhamnosis Ameliorate Liver Fibrosis in Prevention and Treatment.

J Microbiol. 2023-2

[9]
A bibliometric analysis of autophagy in lung diseases from 2012 to 2021.

Front Immunol. 2022

[10]
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism.

Nat Commun. 2022-11-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索